Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on August 8, 2017 Aug 1, 2017 04:05PM
Novavax (NVAX) Says RSV F Vaccine Phase 2 Clinical Trial Data Published in Vaccine Jun 7, 2017 08:08AM
Novavax RSV F Vaccine Phase 2 Clinical Trial Data in Women of Child Bearing Age Published in Vaccine Jun 7, 2017 08:05AM
Novavax Reports First Quarter 2017 Financial Results May 8, 2017 04:05PM
Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017 May 1, 2017 10:57AM
View Older Stories

Feb 27, 2017 04:05PM Novavax Reports Fourth Quarter and Year-End 2016 Financial Results
Feb 20, 2017 04:05PM Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017
Jan 5, 2017 08:05AM Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference
Dec 6, 2016 04:05PM Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference
Nov 30, 2016 04:05PM Novavax to Participate in the Citi 2016 Global Healthcare Conference
Nov 22, 2016 04:05PM Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 9, 2016 04:05PM Novavax Reports Third Quarter 2016 Financial Results
Oct 7, 2016 08:01AM Novavax (NVAX) Reschedules Investor, Analyst Meeting; Wants to Finalize Resolve Trial Data
Oct 7, 2016 08:00AM Novavax Reschedules 4th Annual Investor and Analyst Meeting
Oct 4, 2016 04:05PM Novavax to Host 4th Annual Investor and Analyst Meeting
Sep 15, 2016 04:19PM Novavax (NVAX) Reports RSV F Vaccine Phase 3 Missed Primary, Secondary Efficacy Objectives
Sep 15, 2016 04:18PM Novavax Announces Topline RSV F Vaccine Data from Two Clinical Trials in Older Adults
Sep 7, 2016 04:05PM Novavax to Host 4th Annual Investor and Analyst Meeting
Aug 9, 2016 04:05PM Novavax Reports Second Quarter 2016 Financial Results
Jun 17, 2016 08:30AM Novavax Recognized by Washington Post as Top Workplace
Jun 2, 2016 04:03PM Novavax (NVAX) Announces Presentation of New Seasonal Influenza Nanoparticle Data at HVTD Keystone
Jun 2, 2016 04:02PM Novavax Announces New Seasonal Combination Respiratory Vaccine Program
May 25, 2016 09:14AM Novavax's (NVAX) RSV F Vaccine Granted FDA Fast-Track Designation
May 25, 2016 08:00AM U.S. FDA Grants Fast Track Designation to Novavax’ RSV F Vaccine for Older Adults
May 12, 2016 08:30AM Novavax Receives the Tech Council of Maryland’s Chairman’s Award
May 11, 2016 04:05PM Novavax to Participate in the 2016 Citi Midwest Healthcare Access Day
May 4, 2016 04:05PM Novavax Reports First Quarter 2016 Financial Results
Apr 13, 2016 04:05PM Novavax to Participate in the FBR New Prescriptions Conference
Apr 6, 2016 04:05PM Novavax to Present at the 15th Annual Needham Healthcare Conference
Apr 4, 2016 04:07PM Novavax (NVAX) Appoints New VP of Biostatistics
Apr 4, 2016 04:05PM Novavax Announces Management Promotion
Feb 29, 2016 07:30AM Novavax Reports Fourth Quarter and Year-End 2015 Financial Results
Jan 8, 2016 08:30AM Novavax Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs
Jan 6, 2016 04:02PM Novavax to Present at the 34th Annual J.P. Morgan Healthcare Conference
Dec 21, 2015 04:05PM Novavax Appoints Mark Twyman Vice President Marketing
Dec 14, 2015 04:07PM Novavax (NVAX) Announces Completion of Resolve Enrollment
Dec 14, 2015 04:05PM Novavax Completes Enrollment of Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults
Dec 8, 2015 04:05PM Novavax to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare Conference
Dec 3, 2015 04:05PM Novavax Initiates Global Pivotal Phase 3 Trial of the RSV F Vaccine to Protect Infants via Maternal Immunization
Nov 24, 2015 04:05PM Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference
Nov 16, 2015 04:05PM Novavax to Make Multiple Presentations at RSV Vaccines for the World
Nov 10, 2015 04:05PM Novavax to Present at the Stifel 2015 Healthcare Conference
Nov 9, 2015 06:55AM Novavax Reports Third Quarter 2015 Financial Results
Nov 9, 2015 06:50AM Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults
Nov 2, 2015 04:05PM Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015
Oct 22, 2015 04:02PM Novavax Initiates Phase 2 Safety and Immunogenicity Trial to Evaluate Annual Re-Dosing of the RSV F Vaccine in Older Adults
Oct 1, 2015 04:30PM Novavax Announces Management Promotion
Sep 29, 2015 04:02PM Novavax Announces Positive Top-Line Data From RSV F Vaccine Phase 1 Clinical Trial in Pediatrics
Sep 29, 2015 06:55AM Novavax to Host 3rd Annual Analyst and Investor Meeting
Sep 29, 2015 06:50AM Novavax Announces Positive Top-Line Data from Phase 2 Clinical Trial of RSV F Vaccine to Protect Infants via Maternal Immunization
Sep 29, 2015 06:45AM Novavax Announces Grant of Up to $89 Million to Support Development of RSV F Vaccine to Protect Infants Via Maternal Immunization
Sep 22, 2015 08:00AM Novavax to Host 3rd Annual Analyst and Investor Meeting
Sep 21, 2015 04:30PM Novavax to Present at the Ladenburg Thalmann 2015 Healthcare Conference
Sep 15, 2015 04:30PM Novavax RSV F Vaccine is Highly Immunogenic With Robust Transplacental Antibody Transfer in Preclinical Maternal Immunization Model
Sep 10, 2015 04:30PM Novavax RSV F Vaccine Clinical Trial Data in Women of Child Bearing Age Published in the Journal of Infectious Disease
View Older Stories